|
WO2020053334A1
|
|
A process for the preparation of ozanimod and its intermediate (s)-1-amino-2,3-dihydro-1h-indene-4-carbonitrile
|
|
WO2018036982A1
|
|
Chemical-biocatalytic method for producing ursodeoxycholic acid
|
|
KR20190018675A
|
|
The in vivo transformation coupled with ursodeoxycholic acid of chenodeoxycholic acid and the enzyme mutants applicable to this method
|
|
KR20170036797A
|
|
3-alpha-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid
|
|
US2017226556A1
|
|
7-β-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid
|
|
KR20170020511A
|
|
7- novel method for biocatalytic whole cell reduction of dehydrocholic acid compounds novel -hydroxysteroid dehydrogenase mutants and improved biocatalytic method for producing ursodesoxycholic acid
|
|
WO2014118802A1
|
|
An improved process for the preparation of clopidogrel bisulfate form-i
|
|
EP3456820A1
|
|
New 7beta-hydroxysteriod dehydrogenase mutants and method for producing ursodeoxycholic acid
|
|
MX2013002638A
|
|
Method for producing crystalline 5-aminosalicylic acid.
|
|
AU2011257168A1
|
|
Novel 7alpha-hydroxysteroid dehydrogenase knockout mutants and use thereof
|
|
KR20130065631A
|
|
NOVEL 7β-HYDROXYSTEROID DEHYDROGENASES AND THEIR USE
|
|
EP2441771A1
|
|
New 12alpha-hydroxysteroid dehydrogenase mutants, method for their manufacture and application thereof
|
|
WO2011055378A1
|
|
Improved process for preparation of clopiodogrel bisulfate crystalline form-1
|
|
EP2333101A1
|
|
NAD(P)+-cofactor regeneration system und its use
|
|
EP2327790A1
|
|
New 7ß-hydroxy steroid dehydrogenases and their use
|
|
EP2105500A1
|
|
New 12alpha-hydroxysteroiddehydrogenases, method for their manufacture and application thereof
|
|
AU2001281827B2
|
|
Method for producing 5-aminosalicyclic acid
|
